Skip to main content
Earnings Labs
Pulmonx Corporation logo

Pulmonx Corporation (LUNG)

NASDAQ·Healthcare·Medical - Devices

$2.63

+32.90%

Mkt Cap $95.46M

Analyst Ratings

No recent rating data.

Price Target (10 analysts)

$10.00

Range $2.50 – $20.00

Implied Upside

+280.2%

Consensus $10.00 vs current $2.63